« Return to News | Awards & Advancement

Inovio's chairman elected fellow by AAAS

Wednesday, March 14, 2012 09:16 AM

Inovio Pharmaceuticals’ advisory board chairman David B. Weiner, PhD, has been elected a fellow in the nonprofit American Association for the Advancement of Science (AAAS).

Weiner, sometimes called the "father of synthetic DNA vaccines," was honored for his pioneering and enabling discoveries in the area of synthetic DNA vaccines and promoting the nascent field of research during its early stages. He was recognized at the Fellows Forum held February 18 in Vancouver, Canada.

A professor in the department of pathology and laboratory medicine at the University of Pennsylvania, Weiner helped to found the field of synthetic DNA vaccines in the early 1990s. His laboratory and collaborators were responsible for the first synthetic DNA vaccine Investigational New Drug application (IND). This IND for HIV immune therapy became the first IND approved as a synthetic DNA therapeutic vaccine. His studies were the first to establish that synthetic DNA vaccines appear well tolerated and are immunogenic in humans.

The AAAS Fellowship is based on scientifically or socially distinguished efforts to advance science or its applications. Members have been elected to the organization by their peers since 1874.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.